Showing results (101-110 of 249) with videos related to

Sort By:
Pageof 25
Cancer Immunology, Immunotherapy : CII|July 8, 2005
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodesPer thor Straten, Christina Dahl, David Schrama, et al.
International Journal of Cancer|March 25, 2006
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cellsSine Reker Hadrup, Otto Braendstrup, Grete Krag Jacobsen, et al.
Oncoimmunology|October 21, 2016
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanomaTroels Holz Borch, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.
Cytotherapy|May 22, 2024
Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapyPia Aehnlich, Marta Velasco Santiago, Søren Helweg Dam, et al.
Oncoimmunology|September 28, 2013
High frequency of T cells specific for cryptic epitopes in melanoma patientsRikke Sick Andersen, Sofie Ramskov Andersen, Mads Duus Hjortsø, et al.
Frontiers in Immunology|June 21, 2021
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor AntigensGitte Holmen Olofsson, Manja Idorn, Ana Micaela Carnaz Simões, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 3, 2015
Design and validation of conditional ligands for HLA-B*08:01, HLA-B*15:01, HLA-B*35:01, and HLA-B*44:05Thomas Mørch Frøsig, Jiawei Yap, Tina Seremet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donorsRikke Lyngaa, Natasja Wulff Pedersen, David Schrama, et al.
Pageof 25